Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The association between TyG index and hypertension in middle-aged and elderly Chinese patients: Data from CHALRS

  • Jun Wang,

    Roles Data curation, Writing – original draft, Writing – review & editing

    Affiliation Department of Neurosurgery, Master of Medicine, The First People’s Hospital of Linping District, Hangzhou, Zhejiang Province, China

  • Chao Tang,

    Roles Investigation

    Affiliation Department of Neurosurgery, Bachelor of Medicine, The First People’s Hospital of Linping District, Hangzhou, Zhejiang Province, China

  • Zhijie Xie

    Roles Data curation, Investigation

    1046589573@qq.com

    Affiliation Department of Neurosurgery, Master of Medicine, The First People’s Hospital of Linping District, Hangzhou, Zhejiang Province, China

Abstract

Background

The TyG index is thought to be a trustworthy substitute indicator of insulin resistance. Increasing research evidence shows the correlation between TyG and various cardiovascular and cerebrovascular diseases and adverse prognosis. However, the effect of diabetes on the connection between TyG and hypertension has not been extensively studied. In order to identify high-risk individuals, our research aimed to investigate the potential relationship between the TyG index and the risk of hypertension in middle-aged and elderly Chinese individuals.

Methods

This study analyzed and collected information of the middle-aged and elderly population from the 2015 China Health and Retirement Longitudinal Study (CHARLS) database, and three groups were created based on the tertiles of TyG. First, the clinical characteristics of patients in different groups were analyzed univariately, and logistic regression analysis and RCS model were utilized to further clarify the relationship between the TyG index and hypertension. Finally, subgroup analysis was performed to distinguish the effects of different baseline characteristics on the connection between TyG and hypertension.

Results

9695 patients in all were enrolled, including 4548 males (46.9%) and 5147 females (53.1%). The incidence of hypertension in all patients was 33.7%. As displayed in Table 1, as the TyG index rises, the incidence of Diabetes, Heart disease, and Stroke in patients increased accordingly. Similarly, in terms of laboratory indicators, White blood cell, Platelets, Triglycerides, Uricacid, and Hbg increased with the rises of TyG; while the incidence of lung diseases, BUN, and HDL levels showed a downward trend. The RCS model showed that there was a statistically significant nonlinear association between TyG and hypertension (p value <0.001, nonlinear p = 0.008); Subgroup analysis showed that different baseline characteristics may influence the association between TyG and hypertension risk.

Conclusion

Our study’s findings demonstrate a substantial correlation between TyG index and hypertension, showing a positive correlation in both adjusted and unadjusted logistic regression models, which may help identify individuals at risk for hypertension and have great potential through early improvement of blood pressure management. It has great potential to reduce the occurrence related to cardiovascular and cerebrovascular disorders.

1. Introduction

Hypertension is a prevalent risk factor for cardiovascular and cerebrovascular disorders [1]. The number of people suffering from hypertension has doubled during the previous few decades [2]. Comprehensive survey results show that there are no less than 200 million people with hypertension in China, and more than 1.3 billion people in the world suffer from hypertension [3,4]. As the understanding of hypertension continues to deepen, the treatment of hypertension has also been continuously improved, but the blood pressure control of the population is not ideal [5,6]. Many people with high blood pressure do not show obvious symptoms, but brain hemorrhage and ruptured aneurysms caused by high blood pressure can be fatal. Other complications like coronary artery disease can also be very dangerous and fatal [7]. Therefore, it is crucial to further explore the risk factors of hypertension and take preventive measures.

Insulin resistance (IR) refers to the reduced sensitivity and reactivity to the physiological actions of insulin, which is often closely associated with metabolic syndrome. It is accompanied by abnormal glucose and lipid metabolism, thus promoting the incidence of various cardiovascular and cerebrovascular diseases, and is strongly linked to a poor prognosis [812]. Despite being the gold standard for diagnosing insulin resistance, the glucose clamp technique’s extensive use in clinical practice is limited by its complex and costly procedure [13].

The TyG index is increasingly acknowledged as a trustworthy substitute marker for IR, due to its convenience and affordability [14]. There is a strong association between the rise in TyG index and the severity of glucose and lipid metabolism abnormalities, and also with the growing occurrence of metabolic syndrome in patients. Convincing empirical results from numerous investigations have solidified the correlation between TyG and the incidence and prognosis of cerebrovascular and cardiovascular disorders [15,16]. Another prospective cohort study has also provided more clarification that TyG index serves as a potential indicator of cardiovascular disease risk within populations without diabetes [17]. Nevertheless, limited research has specifically examined the influence of diabetes on the association between TyG and hypertension. Thus, our study sought to use data from CHARLS to evaluate, in middle-aged and elderly Chinese people, the relationship between TyG levels and hypertension, which would be beneficial for early identification and tracking of hypertension and have important implications for early management of hypertension.

2. Methods

2.1. Study population

This retrospective analysis utilized the public dataset of the China Health and Retirement Longitudinal Study (CHARLS), which was conducted in 2011 and covered 150 county-level units, 450 village-level units, and 17,000 people in approximately 10,000 households. It fully represents the high-quality information of families and individuals of middle-aged and elderly people aged 45 and above in China, and contains detailed information on family demographics, household composition, and health status.

The analysis used data from the 2015 CHARLS survey. In total, 9695 subjects aged 45 years or older were enrolled, including 4548 males and 5147 females. Patients with missing clinical data were excluded, and the TyG index was computed utilising relevant laboratory indicators. The patients were categorized and grouped based on the tertiles of TyG. See Fig 1 for details.

This research involves the CHARLS public database. The local Peking University Biomedical Ethics Review Committee has agreed to collect CHARLS data (IRB00001052–11015), and all participants have signed the informed consent form. The research was conducted in accordance with relevant guidelines/regulations, and the method was in line with the ethical guidelines of Helsinki Declaration.

2.2. Definition

Definition of hypertension [18]:(1)Mean diastolic blood pressure ≥90 mmHg or a mean systolic blood pressure ≥140 mmHg; (2) patient’s self-stated hypertension; (3) taking antihypertensive medications as prescribed. These criteria adhere to the standards established by the International Society of Hypertension.

Based on fasting blood glucose and triglyceride levels, the Tyg index is determined by employing the subsequent formula:

TG = fasting triglycerides in mg/dL; FBG = fasting blood glucose in mg/dL; ln = natural logarithm

2.3. Statistical analysis

All analyses were performed utilising the statistical software SPSS26. For data collection, variables with missing data rates greater than 10% were eliminated, variables with missing data rates between 5% and 10% were interpolated using mean interpolation. For variables with a missing rate below 5%, the missing variable is deleted. Initially,the triple digits of the TYG index were calculated based on the 33% and 66th percentile distribution in the study population. Patients were divided into three groups: Q1 (≦8.38), Q2 (8.38 ~ 8.92) and Q3 (>8.92). Kolmogorov–Smirnov test was utilized to test the normal distribution of continuous variables, and the results showed that the TyG index showed a skewed distribution. And the Kruskal-Wallis test was utilized for non-normally distributed continuous data using the median (IQR),the chi-square test was employed to analyze categorical variables, which were presented as n (%). Unadjusted and adjusted logistic regression models were employed to evaluate the link between TyG and hypertension. In smaller modified models, we controlled simply for BMI, age, and diabetes. In the fully adjusted model, all covariates included chronic diseases (Diabetes, Stroke, Heart disease, Lung disease, Arthritis), Age, BMI, WBC, MCV, BUN, Creatinine, Triglycerides, HDL, Uric acid, Hbg. A multicollinearity test was performed on the variables included in the model, and the variance inflation factor VIF was calculated. When VIF < 5, it was considered to have no significant collinearity characteristics. The OR value and 95%CI of the logistic regression model were computed, P < 0.05 was considered statistically significant.In addition, we performed subgroup analysis to distinguish the clinical applicability of TyG under different baseline features.

3. Result

3.1. Baseline characteristics

This investigation included 9695 patients in total, who were categorized based on the TyG Index tertiles. Among them, there were 4548 males (46.9%) and 5147 females (53.1%). The incidence of hypertension was 33.7% in the enrolled patients. According to Table 1, as TyG rises, the incidence of Diabetes(p < 0.001), Heart disease(p < 0.001), Stroke(p = 0.002) in patients increased accordingly. Similarly, in terms of blood pressure and laboratory indicators, WBC(p < 0.001), Plt(p < 0.001), Triglycerides(p < 0.001), Uric acid(p < 0.001), and Hbg(p < 0.001) increased with the rise of TyG; While the incidence of Lung diseases(p = 0.002), BUN(p < 0.001), and HDL(p < 0.001) levels showed a downward trend.

3.2. Associations between TyG and hypertension

Univariate regression analysis was performed on the above variables, and variables (p < 0.05) were included in the multiple logistic regression model. Table 2 displays the multivariate regression analysis’s correlation between TyG and hypertension. The results show the OR values when TyG is used as a categorical and continuous variable. In model 2, covariate included age, BMI, diabetes. When considering as a categorical data, compared to Q1 group, the OR value of hypertension risk in the Q2 group was 1.44 (1.29 ~ 1.62), and the OR value of hypertension risk in the Q3 group was 2.08 (1.86 ~ 2.32). When considering as a continuous data, the risk of hypertension increased by 1.56 (1.46 ~ 1.68) times for each unit rise in the TyG Index (P < 0.001). In model 3, all adjustment variables were included. Compared with group Q1, the OR of hypertension in group Q2 was 1.32(1.17 ~ 1.49), and the OR of hypertension in group Q3 was 1.72(1.45 ~ 2.02). As a continuous variable, the risk of hypertension increased by 1.57(1.34 ~ 1.84) times for each unit rise in the TyG Index (P < 0.001). In general, higher TyG index is positively correlated with the occurrence of hypertension.

thumbnail
Table 2. Connection between TyG and risk of hypertension.

https://doi.org/10.1371/journal.pone.0329234.t002

After including all covariates, including: Age, Diabetes,Stroke, Heart disease, Lung disease, Arthritis, BMI, WBC, MCV, BUN, Creatinine, Triglycerides, HDL, Uric acid, Hbg. The RCS curve analysis in Fig 2 demonstrated a nonlinear association between TyG and hypertension (p value < 0.05, nonlinear p < 0.05).

thumbnail
Fig 2. RCS curve is the odds ratio of TyG index.

All covariates included in the model include: Age, Diabetes, Stroke, Heart disease, Lung disease, Arthritis, BMI, WBC, MCV, BUN, Creatinine, Triglycerides, HDL, Uric acid, Hbg. OR: odds ratio; CI, confidence interval; RCS, restricted cubic spline.

https://doi.org/10.1371/journal.pone.0329234.g002

3.3. Subgroup analysis

In addition, we performed subgroup analyses to examine the association between TyG and hypertension in patients with different baseline characteristics. After all covariables were included in model 3, Fig 3 showed the OR value of interaction between TyG index and hypertension and P for interaction of each subgroup. As can be seen in Fig 3, there is a significant interaction in gender (interaction P = 0.037), which may affect the relationship between TyG index and hypertension risk. The results of the forest map show that the OR values of all subgroups are greater than 1, indicating that the risk of hypertension increases with the increase of TyG index. Overall, there was no significant interaction between most groups. In addition, the RCS relationship between TyG index and hypertension under several common different baseline characteristics is drawn. As shown in Figs 4 and 5, there is no significant correlation between the risk of hypertension and TyG in diabetic patients, but in non-diabetic patients, the TyG index is linearly positively correlated with hypertension. In Figs 6 and 7, there is a positive linear correlation between the risk of hypertension and TyG in female patients, but there is no significant correlation between the TyG index and hypertension in male patients.

thumbnail
Fig 3. Subgroup analysis of correlation between TYG index and hypertension.

https://doi.org/10.1371/journal.pone.0329234.g003

thumbnail
Fig 4. Represents the hypertension risk curve for non-diabetic patients.

https://doi.org/10.1371/journal.pone.0329234.g004

thumbnail
Fig 5. Represents the hypertension risk curve for diabetic patients.

https://doi.org/10.1371/journal.pone.0329234.g005

thumbnail
Fig 6. Represents the hypertension risk curve for female patients.

https://doi.org/10.1371/journal.pone.0329234.g006

thumbnail
Fig 7. Represents the hypertension risk curve for male patients.

https://doi.org/10.1371/journal.pone.0329234.g007

4. Discussion

In this cross-sectional study based on middle-aged and elderly Chinese population. We examined the correlation between hypertension and TyG, and our findings demonstrated a significant association between higher TyG and the risk of hypertension. Furthermore, the prevalence of diabetes, heart disease, and stroke had a positive correlation with TyG. The strong correlation between TyG and hypertension persisted even after accounting for traditional risk variables. According to these results, the TyG index is independently correlated with hypertension and could be used to monitor and identify those who are at risk for the condition. Furthermore, the RCS findings revealed a nonlinearly positive correlation between the risk of hypertension and the alteration in TyG index.

TyG index is an invaluable surrogate indicator of IR that is commonly employed and is determined by fasting triglyceride and blood glucose levels. Increasing research evidence has proven that higher TyG is significantly correlated to diabetes, hypertension, chronic kidney disease, cardiovascular disease, coronary artery calcification, etc [14,1922]. In our investigation, we also found similar outcomes, which could be connected to the following mechanisms.

IR is a condition in which the body’s capacity to absorb and metabolize glucose and its sensitivity to insulin are diminished. Due to insulin resistance, the increase of free fatty acids in blood, making them more likely to be deposited in other organs such as the liver, cardiovascular, cerebrovascular systems, etc [23]. Many other research have also validated that compensatory hyperinsulinemia is an independent risk factor for atherosclerotic heart disease and hypertension [22,2426]. Furthermore, insulin resistance is linked to chronic inflammation of the blood vessel wall, oxidative stress, and endothelial dysfunction, which further leads to vascular stiffness and elevated blood pressure [8,27], which may partially explain the increased incidence of cerebrovascular disease and hypertension at the center of this study. Recent research examining the correlation between TyG index and the risk of cardiovascular disease in older adults has discovered a heightened risk of cardiovascular disease, consistent with the findings of this study [28,29]. On this basis, we further performed subgroup analysis and plotted forest maps to explore whether different baseline characteristics would affect the association between TyG and cardiovascular disease.

Numerous epidemiological research have demonstrated that association between high TyG index and hypertension risk and serving as a valid proxy for insulin resistance [3033]. Interestingly, there was no discernible correlation between TyG index and hypertension within diabetic patients according to the results of our subgroup study. While the precise mechanism remains unclear, the administration of hypoglycemic medications or insulin in diabetic patients can potentially impact the real levels of blood sugar and insulin in the body. Moreover, diabetes can significantly influence the advancement of hypertension and is also a significant risk element [17]. Additional study has indicated that diabetes and hyperlipidemia can potentially impact the accuracy of using the TyG index for evaluating cardiovascular disease [34]. Therefore, TyG may not accurately represent the actual state of glucose and lipid metabolism individuals with diabetes, so the connection between TyG index and hypertension may be masked. Moreover, there seems to be no clear correlation between male TyG index and hypertension risk in different gender subgroups. A study by Lu et al. Gender differences in the relationship between TyG index and atherosclerosis pointed out that differences in fat storage sites in different sexes may affect IR development. Compared with men, women have greater changes in lipid status and metabolic deterioration when increasing the same fat storage level [35]. Additionally, many studies have revealed the correlation between estrogen deficiency and insulin resistance [36]. M R Meyer [37] research pointed out that women are more likely to accelerate obesity after menopause, which may be related to the lack of estrogen after menopause and has been confirmed by many animal experiments [38].

Our research also strengthens this view. The research object is middle-aged and elderly women, and the lack of estrogen is more likely to cause insulin resistance and obesity.

Therefore, it may be necessary to adopt a gender-specific method to identify individuals at risk of hypertension by using TyG index.Actively looking for risk factors related to the development of hypertension and improving blood pressure management have great potential to reduce the occurrence of various disease events such as cardiovascular and cerebrovascular diseases.

Nevertheless, it is important to recognize that this study does have certain constraints. Firstly, our study subjects were middle-aged and elderly Chinese individuals, the findings may lack generalizability to individuals from different age cohorts or diverse ethnic backgrounds. Secondly, as a cross-sectional observational study, we have solely identified a correlation between TyG and hypertension. We cannot exclude the potential of a reverse causal connection between them, which still needs further study. Finally, for different clinical characteristics (including diabetes and gender, etc.), which may affect the correlation between TyG and the risk of cardiovascular diseases such as hypertension, further research is needed to explore the underlying mechanism.

5. Conclusion

According to our findings, different baseline characteristics may affect the relationship between TyG index and hypertension risk. Elevated TyG index in women and non-diabetic patients is associated with an increased risk of hypertension, and individualized risk management strategies are still needed for early prevention of hypertension risk.

References

  1. 1. Muiesan ML, Salvetti M, Fragoulis C, Paini A, Bertacchini F, Stassaldi D, et al. Cardiovascular risk and outcome in patients with hypertensive emergencies and urgencies in an emergency department. an italian greek collaboration. European Heart J. 2020;41(Supplement_2).
  2. 2. AlAhmad M, Beiram R, AbuRuz S. Application of the American College of Cardiology (ACC/AHA) 2017 guideline for the management of hypertension in adults and comparison with the 2014 Eighth Joint National Committee Guideline. J Saudi Heart Assoc. 2021;33(1):16–25. pmid:33936937
  3. 3. Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z. Status of hypertension in china: results from the china hypertension survey, 2012-2015. Circulation. 2018;137(22):2344–56.
  4. 4. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.
  5. 5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. pmid:34450083
  6. 6. Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324(12):1190–200.
  7. 7. Pokharel Y, Karmacharya BM, Neupane D. Hypertension-a silent killer without global bounds: what next? J Am Coll Cardiol. 2022;80(8):818–20.
  8. 8. Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. pmid:33766485
  9. 9. Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Vascular stiffness in insulin resistance and obesity. Front Physiol. 2015;6:231. pmid:26321962
  10. 10. Zhao J, Fan H, Wang T, Yu B, Mao S, Wang X, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123. pmid:35778734
  11. 11. Liu D, Yang K, Gu H, Li Z, Wang Y, Wang Y. Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus. Cardiovasc Diabetol. 2022;21(1):280. pmid:36510223
  12. 12. Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019;13(2):1449–55. pmid:31336505
  13. 13. Wang Y, Wang S, Pan X, Meng P, Yang J, Zhang Y, et al. Association between triglyceride-glucose index and arterial stiffness reflected by carotid pulse-wave velocity in stage 1 hypertension and individuals with normal/elevated blood pressure. J Clin Hypertens (Greenwich). 2023;25(2):199–212. pmid:36695004
  14. 14. Wang S, Shi J, Peng Y, Fang Q, Mu Q, Gu W, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20(1):82. pmid:33888131
  15. 15. Wang Z, Hui X, Huang X, Li J, Liu N. Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification. BMC Endocr Disord. 2022;22(1):274. pmid:36357872
  16. 16. Cheng L, Zhang F, Xue W, Yu P, Wang X, Wang H, et al. Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0. Cardiovasc Diabetol. 2023;22(1):142. pmid:37330498
  17. 17. Liu L, Wu Z, Zhuang Y, Zhang Y, Cui H, Lu F, et al. Association of triglyceride-glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study. Cardiovasc Diabetol. 2022;21(1):256. pmid:36434636
  18. 18. Boffa RJ, Constanti M, Floyd CN, Wierzbicki AS, Guideline Committee. Hypertension in adults: summary of updated NICE guidance. BMJ. 2019;367:l5310. pmid:31636059
  19. 19. Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. Transl Res. 2021;228:42–51.
  20. 20. Shan S, Li S, Lu K, Cao J, Sun W, Zhou J, et al. Associations of the triglyceride and glucose index with hypertension stages, phenotypes, and their progressions among middle-aged and Older Chinese. Int J Public Health. 2023;68:1605648. pmid:37020526
  21. 21. Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34. pmid:36797706
  22. 22. Fan Y, Yan Z, Li T, Li A, Fan X, Qi Z. Primordial drivers of diabetes heart disease: comprehensive insights into insulin resistance. Diabetes Metab J. 2024;48(1):19–36.
  23. 23. Li Q, Zhao M, Wang Y, Zhong F, Liu J, Gao L, et al. Associations between serum free fatty acid levels and incident diabetes in a 3-year cohort study. Diabetes Metab Syndr Obes. 2021;14:2743–51. pmid:34168474
  24. 24. Lee KS, Feltner FJ, Bailey AL, Lennie TA, Chung ML, Smalls BL, et al. The relationship between psychological states and health perception in individuals at risk for cardiovascular disease. Psychol Res Behav Manag. 2019;12:317–24. pmid:31191053
  25. 25. Fazio S, Mercurio V, Affuso F, Bellavite P. The negative impact of insulin resistance/hyperinsulinemia on chronic heart failure and the potential benefits of its screening and treatment. Biomedicines. 2023;11(11).
  26. 26. Tan L, Liu Y, Liu J, Zhang G, Liu Z, Shi R. Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study. Cardiovasc Diabetol. 2023;22(1):311. pmid:37946205
  27. 27. Jia G, Sowers JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78(5):1197–205.
  28. 28. Wang Y, Chen X, Shi J, Du M, Li S, Pang J, et al. Relationship between triglyceride-glucose index baselines and trajectories with incident cardiovascular diseases in the elderly population. Cardiovasc Diabetol. 2024;23(1):6. pmid:38172936
  29. 29. Liang D, Liu C, Wang Y. The association between triglyceride-glucose index and the likelihood of cardiovascular disease in the U.S. population of older adults aged ≥ 60 years: a population-based study. Cardiovasc Diabetol. 2024;23(1):151.
  30. 30. Wang K, He G, Zhang Y, Yin J, Yan Y, Zhang Y, et al. Association of triglyceride-glucose index and its interaction with obesity on hypertension risk in Chinese: a population-based study. J Hum Hypertens. 2021;35(3):232–9. pmid:32203074
  31. 31. Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16(1):175. pmid:28903774
  32. 32. Zhu B, Wang J, Chen K, Yan W, Wang A, Wang W, et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction Study. Cardiovasc Diabetol. 2020;19(1):112. pmid:32664945
  33. 33. Lee D-H, Park JE, Kim SY, Jeon HJ, Park J-H. Association between the triglyceride-glucose (TyG) index and increased blood pressure in normotensive subjects: a population-based study. Diabetol Metab Syndr. 2022;14(1):161. pmid:36309720
  34. 34. Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8.
  35. 35. Lu Y-W, Chang C-C, Chou R-H, Tsai Y-L, Liu L-K, Chen L-K, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021;20(1):206. pmid:34645432
  36. 36. De Paoli M, Zakharia A, Werstuck GH. The role of estrogen in insulin resistance: a review of clinical and preclinical data. Am J Pathol. 2021;191(9):1490–8. pmid:34102108
  37. 37. Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011;203(1):259–69. pmid:21281456
  38. 38. Stubbins RE, Najjar K, Holcomb VB, Hong J, Núñez NP. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab. 2012;14(1):58–66. pmid:21834845